Mr. David Traylor
Senior Managing Director, Golden Eagle Partners
David Traylor is Senior Managing Director at Golden Eagle Partners, a firm he founded in 2012 to advise life science companies. After advising on various transactions in the life science sector, he took an interest in the cannabis sector and started advising cannabis companies in 2013. In 2014, he joined Surna, Inc. (OTC:SRNA) as Chief Business Officer. After close to a year stint at Surna, David re-founded Golden Eagle Partners to provide his knowledge to companies across the cannabis sector.
Before Golden Eagle Partners, David led the Life Science group at Headwaters MB, a leading boutique investment bank. Before Headwaters, David served as a Senior Vice President at Caris & Company where he was focused on biopharmaceuticals. He also previously worked at Pacific Growth Equities, which later became Wedbush. During his banking tenures he has advised private and public biotechnology and medical device companies in various transactions including IPOs, public offerings, private offerings, mergers and acquisitions totaling over $500 million in value.
Before investment banking, David spent fifteen years in diverse operational roles in biotechnology companies, from research and development to business development, manufacturing, program management and senior management.
David began his career in biotechnology, with a position in bioprocess manufacturing at Synergen (acquired by Amgen), and then moved into R&D and process development positions at Somatogen, a company pursuing a recombinant blood substitute. After Somatogen (acquired by Baxter), he led the management of programs and development initiatives at Affymetrix (acquired by Thermo Fisher), the leading innovator in microarray technology. David began his business development career at Deltagen then moved over the lead the U.S. operations for atugen AG (acquired by Silence Therapeutics), a Berlin-based functional genomics company. At Bioseek (acquired by Asterand), David led the business development efforts for one of the first systems biology companies.
In 1988, David was one of five Colorado players selected to play for the Denver Rifles in the American Lacrosse League (ALL) – the first U.S. professional field lacrosse league. David remains active in athletics and is parlaying his athletic background and knowledge in cannabis as a valuable member of Athletes for Care.
David received B.A. degrees from the University of Colorado, Boulder in Biochemistry and Molecular, Cellular and Developmental Biology and an M.B.A. from the Leeds School of Business at the University of Colorado-Boulder. He is also the inventor on three issued U.S. patents.
David holds the Series 7, 63 and 66 securities licenses.